NO20012986L - Kontrollert frigivende formulering av natrium divalproex - Google Patents

Kontrollert frigivende formulering av natrium divalproex

Info

Publication number
NO20012986L
NO20012986L NO20012986A NO20012986A NO20012986L NO 20012986 L NO20012986 L NO 20012986L NO 20012986 A NO20012986 A NO 20012986A NO 20012986 A NO20012986 A NO 20012986A NO 20012986 L NO20012986 L NO 20012986L
Authority
NO
Norway
Prior art keywords
controlled release
release formulation
divalproex
sodium divalproex
sodium
Prior art date
Application number
NO20012986A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012986D0 (no
Inventor
Yihong Qui
Richard Paul Poska
Howard S Cheskin
J Daniel Bollinger
Robert Kevin Engh
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/216,650 external-priority patent/US6419953B1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20012986D0 publication Critical patent/NO20012986D0/no
Publication of NO20012986L publication Critical patent/NO20012986L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20012986A 1998-12-18 2001-06-15 Kontrollert frigivende formulering av natrium divalproex NO20012986L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/216,650 US6419953B1 (en) 1998-12-18 1998-12-18 Controlled release formulation of divalproex sodium
US12155799P 1999-02-25 1999-02-25
PCT/US1999/029204 WO2000037055A1 (en) 1998-12-18 1999-12-09 Controlled release formulation of divalproex sodium

Publications (2)

Publication Number Publication Date
NO20012986D0 NO20012986D0 (no) 2001-06-15
NO20012986L true NO20012986L (no) 2001-08-15

Family

ID=26819594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012986A NO20012986L (no) 1998-12-18 2001-06-15 Kontrollert frigivende formulering av natrium divalproex

Country Status (25)

Country Link
EP (1) EP1140034B1 (de)
JP (1) JP2003513882A (de)
KR (1) KR20010101295A (de)
CN (1) CN1335769A (de)
AR (1) AR021443A1 (de)
AT (1) ATE254907T1 (de)
AU (1) AU2478900A (de)
BG (1) BG105665A (de)
BR (1) BR9916361A (de)
CA (1) CA2330480C (de)
CO (1) CO5160287A1 (de)
CZ (1) CZ20012201A3 (de)
DE (1) DE69913197T2 (de)
DK (1) DK1140034T3 (de)
ES (1) ES2212667T3 (de)
HK (1) HK1043043B (de)
HU (1) HUP0105463A3 (de)
IL (1) IL143407A0 (de)
NO (1) NO20012986L (de)
PL (1) PL356899A1 (de)
PT (1) PT1140034E (de)
SI (1) SI20624A (de)
SK (1) SK8252001A3 (de)
TW (1) TW585788B (de)
WO (1) WO2000037055A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419953B1 (en) 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
US6713086B2 (en) 1998-12-18 2004-03-30 Abbott Laboratories Controlled release formulation of divalproex sodium
US6511678B2 (en) 1998-12-18 2003-01-28 Abbott Laboratories Controlled release formulation of divalproex sodium
US20020025341A1 (en) * 1998-12-18 2002-02-28 Yihong Qiu Controlled release formulation of divalproex sodium
US6528090B2 (en) 1998-12-18 2003-03-04 Abbott Laboratories Controlled release formulation of divalproex sodium
WO2002051402A1 (en) * 2000-12-22 2002-07-04 Abbott Laboratories Controlled release formulation of divalproex sodium
IL158959A (en) * 2001-05-25 2010-06-30 Cephalon Inc Solid pharmaceutical formulations comprising modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040005357A1 (en) * 2002-07-03 2004-01-08 Sherman Bernard Charles Extended-release tablets comprising divalproex sodium
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
CA2518734A1 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
US7713550B2 (en) 2004-06-15 2010-05-11 Andrx Corporation Controlled release sodium valproate formulation
WO2006025029A2 (en) * 2004-08-31 2006-03-09 Ranbaxy Laboratories Limited Extended release composition of divalproex
CN101124209A (zh) * 2005-01-26 2008-02-13 依兰药物国际有限公司 含有抗精神病药物的控释组合物
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
JP5866279B2 (ja) * 2009-05-12 2016-02-17 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ 脱毛防止又は育毛促進のための組成物
WO2012121862A2 (en) * 2011-02-17 2012-09-13 University Of Florida Research Foundation Valproic acid derivative compounds
CN102138911B (zh) * 2011-03-28 2012-12-12 孙卫东 一种双丙戊酸钠缓释片及其制备方法
CN102895201B (zh) * 2011-07-26 2014-09-10 北大方正集团有限公司 丙戊酸半钠片剂及其制备方法
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
CN105012264B (zh) * 2014-04-16 2019-11-29 四川科瑞德制药股份有限公司 丙戊酸钠缓释片及其制备工艺和用途
CN106389368B (zh) * 2015-07-29 2021-11-12 四川科瑞德制药股份有限公司 一种丙戊酸钠缓释制剂及其制备工艺和用途
CN105456218A (zh) * 2015-12-07 2016-04-06 黑龙江省智诚医药科技有限公司 一种丙戊酸镁缓释片及其制备方法
CN107028907B (zh) * 2016-02-04 2021-05-14 成都康弘药业集团股份有限公司 一种双丙戊酸钠缓释片
CN114681419A (zh) * 2020-12-28 2022-07-01 湖南省湘中制药有限公司 一种丙戊酰胺缓释片的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
IL96311A (en) * 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
TW224049B (de) * 1991-12-31 1994-05-21 Sunkyong Ind Ltd
TW222585B (de) * 1992-09-11 1994-04-21 Hoechst Ag
JP3552285B2 (ja) * 1993-08-03 2004-08-11 三菱化学株式会社 経口コレステロール低下剤
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity

Also Published As

Publication number Publication date
AR021443A1 (es) 2002-07-17
AU2478900A (en) 2000-07-12
HUP0105463A2 (hu) 2002-05-29
IL143407A0 (en) 2002-04-21
PT1140034E (pt) 2004-03-31
KR20010101295A (ko) 2001-11-14
NO20012986D0 (no) 2001-06-15
SI20624A (sl) 2002-02-28
CO5160287A1 (es) 2002-05-30
CA2330480C (en) 2002-05-21
EP1140034B1 (de) 2003-11-26
DE69913197D1 (de) 2004-01-08
SK8252001A3 (en) 2001-12-03
DE69913197T2 (de) 2004-09-02
CN1335769A (zh) 2002-02-13
TW585788B (en) 2004-05-01
CA2330480A1 (en) 2000-06-29
ES2212667T3 (es) 2004-07-16
HK1043043B (en) 2004-09-10
ATE254907T1 (de) 2003-12-15
PL356899A1 (en) 2004-07-12
DK1140034T3 (da) 2004-03-08
BG105665A (bg) 2002-03-29
WO2000037055A1 (en) 2000-06-29
HK1043043A1 (en) 2002-09-06
CZ20012201A3 (cs) 2001-09-12
JP2003513882A (ja) 2003-04-15
HUP0105463A3 (en) 2003-03-28
EP1140034A1 (de) 2001-10-10
BR9916361A (pt) 2002-11-05

Similar Documents

Publication Publication Date Title
NO20012986D0 (no) Kontrollert frigivende formulering av natrium divalproex
NO994946D0 (no) Formuleringer med forlenget frigivelse av erytromycinderivater
IS2325B (is) Örgerðar samsetningar epleróns
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
EE03426B1 (et) Risperidooni vesilahuselised ravimvormid
ID29021A (id) Komposisi galantamina pelepasan terkontrol
PT1066027E (pt) Composicao farmaceutica de topiramato
PT954292E (pt) Formulacoes farmaceuticas de libertacao retardada de farmaco
PT1109558E (pt) Formulacoes de ranolazina de libertacao controlada
HUP0102128A3 (en) Mediciaments containing benzimidazole derivatives as modulators of ige
LU90115B1 (fr) Formulation orale de 2-méthyl-thiéno-benzodiazépine
HUP0103707A3 (en) Formulation of stable oxalyplatinum solution
PT1109449E (pt) Formulacoes de microcapsulas
AR027907A1 (es) Composicion de liberacion controlada
PT1028718E (pt) Formulacao de libertacao prolongada
NO981166D0 (no) Fremstilling av askorbylmonofosfater
DE59903028D1 (de) Levothyroxin natrium enthaltende pharmazeutische zubereitung
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO971329D0 (no) Fosforsyrreestere av alkyl- og acyl-dianhydro-1,4:3,6-D-glucitol, deres fremstilling og anvendelse
PT983249E (pt) Procesos e intermediarios para a preparacao de derivados de indazole substituidos
ID25524A (id) Komposisi pasta natrium sianida
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
EP1005474A4 (de) Herstellung von polyorganophosphazenen
SE9802197D0 (sv) Formulations of busulphan
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application